Key facts
- Correction issued for Oberland Biotech GmbH's seed funding announcement.
- The CHF 2.5 million seed funding round was supported by Kataria.
- Original news release was issued on May 1, 2026.
A correction has been issued for a news release originally published on May 1, 2026, by Oberland Biotech GmbH via PR Newswire. The release detailed the company securing CHF 2.5 million in seed funding to support global expansion in biotechnology and food innovation. The correction specifically clarifies that the funding round received support from Kataria.